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A key contributor to the pathophysiology of diabetic cardiomyopathy, mitochondrial superoxide can be
adequately countered by Mn-superoxide dismutase, which constitutes the ﬁrst line of defense against
mitochondrial oxidative stress. Our group has recently synthesized low molecular weight SOD mimics,
demonstrating superior protection against oxidative damages to kidney cells. In the current study, we
sought to evaluate the protective effect of the SOD mimic ML1 against high glucose induced cardio-
myopathy in diabetes. Mechanistic studies using rat cardiac myoblast H9c2 showed that ML1 markedly
inhibited High Glucose (HG) induced cytotoxicity. This was associated with increased Mn-SOD expres-
sion along with decreased mitochondrial ·−O2 , ONOO- and Ca
2þ accumulation, unveiling its anti-oxidant
potentials. ML1 also attenuated HG-induced loss of mitochondrial membrane potential (ΔΨm) and re-
lease of cytochrome c, suggesting that ML1 effectuates its cytoprotective action via the preservation of
mitochondrial function. In an ex-vivo model normal adult rat ventricular myocytes (ARVMs) were iso-
lated and cultured in either normal glucose (5.5 mmol/l glucose) or HG (25.5 mmol/l glucose) conditions
and the efﬁciency of ML-1 was analyzed by studying contractile function and calcium indices. Mechanical
properties were assessed using a high-speed video-edge detection system, and intracellular Ca2þ tran-
sients were recorded in fura-2–loaded myocytes. Pretreatment of myocytes with ML1 (10 nM) amelio-
rated HG induced abnormalities in relaxation including depressed peak shortening, prolonged time to
90% relenghthening, and slower Ca2þ transient decay. Thus, ML1 exhibits signiﬁcant cardio protection
against oxidative damage, perhaps through its potent antioxidant action via activation of Mn-SOD.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diabetic cardiomyopathy remains the most debilitating and
challenging feature of diabetes progression. Hyperglycemia, a
hallmark of diabetes is known to be intimately associated with
ventricular dysfunction that can lead to severe cardiac impairment
and cell death [1–5]. Currently available pharmacologicalB.V. This is an open access article u
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tec. Pvt Ltd., Lalru, Mohali,
und Floor, Wing B, Tower–8,
htra, India.measures for managing hyperglycemia are principally designed
around achieving strict blood glucose control in diabetic patients.
Although these approaches slow down the progression of cardiac
damage, they fail to ultimately prevent the development of car-
diomyopathy (DCM). Thus, additional strategies to protect the
heart against diabetes-induced cardiac dysfunction are required.
Hyperglycemia results in the generation of Oxidative stress,
induced by superoxide generation ( ·−O2 ) and, associated nitrosative
damage, which contribute indisputably to disease progression
culminating in DCM [6,7]. Mitochondria are the major source of
reactive oxygen species (ROS) and Mitochondrial oxidative stress
has been implicated to be primarily responsible for these dele-
terious effects [8–12]. Hence, novel approaches to block excessive
·−O2 generation in diabetic mitochondria may offer a therapeutic
beneﬁt by preventing the development of DCM. Superoxide dis-
mutase (SOD) is an endogenous anti-oxidant, which combatsnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Therefore, the development of therapeutics aimed at mimicking
SOD could provide tactical advantage.
Small molecular weight, manganese porphyrins have been shown
to be of great therapeutic value in a variety of disease processes,
including diabetes [13], myocardial ischemia–reperfusion injury [14],
dilated cardiomyopathy [15], amyotrophic lateral sclerosis (ALS) [16],
retinal injury [17] and epilepsy [18]. The protective effects of man-
ganese porphyrins have been attributed to their antioxidant prop-
erties, including SOD-mimicking and radical scavenging activity [19–
21]. In addition, the manganese porphyrins are cell permeable,
making it possible to provide both intracellular and extracellular
protection against oxidative stress. In our previous study, we have
demonstrated that certain novel synthetic manganese complexes of
α-heterocyclicthiosemicarbazone ligands show superior protection
against oxidative damages to Hek293 kidney cells. These complexes
mimic the structural features of the core motif of Mn-SOD [22]. In the
current study, we evaluated the protective effects of one of these Mn-
SOD mimetics ML-1, against diastolic dysfunction in DCM. We de-
monstrate that this compound exhibits signiﬁcantly enhanced pro-
tection against high glucose injury, presumably due to a combination
of anti-oxidative and calcium regulatory mechanisms.2. Materials and methods
2.1. Chemicals
ML1 is a ﬁve co-ordinate ternary manganese complex prepared
by employing combination of tri-dentate thiosemicarbazone li-
gands and bi-dentate bipyridyl/aminoethanethiol as ancillary li-
gands as previously reported [22]. 3-(4,5-Dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT), 4′,6-diamidino-2-
phenylindole (DAPI), dimethyl sulfoxide (DMSO), D-glucose, were
purchased from sigma, 9-[4-[bis[2-[(acetyloxy)methoxy]-2-ox-
oethyl]amino]-3-[2-[2-[bis[2- [(acetyloxy) methoxy]-2 oxoethyl]
amino] phenoxy] -ethoxy] phenyl] -3, 6-bis(dimethylamino)-
bromide (Rhod 2 AM), MitoSOX red, dihydrorhodamine-123 (DHR-
123) 3,3′-dihexyloxacarbocyanine iodide (DiOC6) and Ionomycin
were from molecular Probes, Invitrogen. xanthine, xanthine oxi-
dase, calcium chloride, EGTA, mn-SOD and mn-SOD antibody were
purchased from sigma-Aldrich (st. louis, MO). PARP antibody was
from BD biosciences.
2.2. Cell cultures and treatments
H9c2 cells (ATCC CLR-1446; Rockville, MD) were maintained in
Dulbecco's modiﬁed Eagle's medium (DMEM) supplemented with
10% fetal bovine serum (FBS) from Gibco, USA. When cell popu-
lations reached 40–50% conﬂuence, the cultures were exposed to
D-glucose in a ﬁnal concentration of 33 mM in cultures and was
termed high glucose (HG) according to previous publications
[1,23] and 5.5 mM concentrationwas used as normal glucose (NG).
Varying concentrations of ML1 were used for the initial experi-
ments (0–100 nM). 0.1 mM Xanthineþ0.01 U Xanthine oxidase
(XþXO, superoxide generator) and 100U Mn-SOD were used as
positive controls. Independently, for various experimental con-
trols, cells were also treated with Calcium (1 μM), calcium chelator
EGTA (10 μM) and Ionomycin (5 μg/ml). After exposure for desired
time periods, the monolayer cultures were washed with PBS and
the cells were removed by trypsinization. In some experiments,
the cells were grown on glass coverslips, which were used for
calcium, ROS and RNS detection and mitochondrial membrane
potential.2.3. Cell viability
For determination of cell viability, 3.5104 cells/well in a 96-
well microplate were incubated in 100 μl of culture media and
exposed to 5.5 and 33 mM of glucose with or without various
concentrations of ML1 (0–100 nM) and 100U Mn-SOD for varying
time periods. 0.1 mM Xþ0.01U XO (superoxide generator) was
used as a positive control. The media were removed again and
replaced with 90 μl of DMEM (containing no phenol red or FBS)
and 10 μl of MTT solution (2 mg/ml phosphate buffer) for 4 h. After
the MTT-containing DMEM was removed, the remaining formazan
blue crystals were dissolved in 100 μl of DMSO solution. Absor-
bance at 570 nm was measured using a microplate reader (Mole-
cular Devices, SpectraMax 250). The cytotoxicity curve was con-
structed from at least three independent experiments and ex-
pressed as percentage cell viability compared to control.
2.4. Mitochondrial superoxide and peroxynitrite generation
Mitochondrial superoxide generation was detected by using a
speciﬁc mitochondrial superoxide indicator, MitoSOX™ red [24], a
modiﬁed cationic dihydroethidium. MitoSOX™ red is a cell-per-
meative dye that reacts with superoxide to form ethidium, which
upon binding to nucleic acids gives a bright red ﬂuorescence.
Brieﬂy, after 48 h HG treatment, the cells grown on specialized
coverslips were loaded with MitoSOX™ red (5 μM; 10 min at
37 °C). Peroxynitrite was measured using DHR 123 (5 μM) [25–27].
After being stained, the cells were washed in PBS and ﬁxed with
10% buffered formalin. Coverslips were mounted on glass slides
and observed using a confocal laser-scanning microscope (Zeiss
CLSM 510) with a 63X objective. Three ﬁelds per image chosen at
random, from 3 independently performed experiments were used
for quantiﬁcation.
2.5. Measurement of mitochondrial calcium
Mitochondrial calcium was measured by incubating the cells
with 2 μM Rhod-2 AM dye. Brieﬂy, after 48 h HG treatment, the
cells, grown on specialized coverslips were loaded with Rhod-2
AM (2 μM; 10 min at 37 °C). After being stained, the cells were
washed in PBS and ﬁxed with 10% buffered formalin. Coverslips
were mounted on glass slides and observed using a confocal laser-
scanning microscope (Zeiss CLSM 510) with a 63X objective. Three
ﬁelds per image chosen at random, from 3 independently per-
formed experiments were used for quantiﬁcation.
2.6. Determination of mitochondrial membrane potential (ΔΨm) and
assessment of mitochondrial cytochrome c release
The mitochondrial membrane potential (ΔΨm) was assessed
using DiOC6 [27,28]. Brieﬂy, H9c2 cells were cultured in six-well
plates and treated with 5.5 and 33 mM of glucose with or without
ML1 (10 nM) and 100U Mn-SOD for 48 h. Subsequently, cells were
loaded with 60 nM DiOC6 for the last 30 min and washed and
images were captured using a confocal microscope as described
above.
Evaluation of the sub-cellular localization of cytochrome c was
done by using confocal imaging of cells double-labeled with Mi-
toTracker™Red (Molecular Probes) and cytochrome c antibody
(Cell Signaling) according to previous methods [23]. Brieﬂy, cells
treated with NG and HG for 72 h were incubated with 100 nM
MitoTracker™ Red, ﬁxed with 3% paraformaldehyde, permeabi-
lized with 0.02% Triton X and blocked with 5% BSA, followed by
incubation with primary rabbit polyclonal cytochrome c antibody
(1:50) for 2 h at room temperature and Cy2-conjugated goat anti-
rabbit antibody (1:500; Chemicon International, Temecula, CA,
Fig. 1. ML1 prevents cardiomyoblast cell death. (A) Cytoprotective effect of ML1 was assessed using MTT assay against HG induced cell death. NG treated wells were
normalized to 100% cell viability. (B) Cytoprotective effect of ML1 was assessed using MTT against oxidative stress induced cell death. XþXO was used as a superoxide
generator. Control wells were normalized to 100% cell viability. Columns, mean from three independent experiments performed in triplicate; bars, SE. ns40.05 versus NG
and HG, **Po0.01 versus NG and #Po0.05 versus HG or XþXO as appropriate. (C) PARP cleavage was studied by western blotting. β actin was used as loading control. Image
representative of three independent experiments.
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slides and images were acquired using a confocal microscope.
Untreated unstained cells served as negative control and untreated
ﬂuorophores loaded cells served as control for background sub-
traction for confocal experiments.2.7. Analysis of Mn-SOD and PARP cleavage
To analyze PARP cleavage [29], and Mn-SOD expression, cells
(3.5104) were treated with 5.5 and 33 mM glucose with or
without various concentrations of ML1 and 100U Mn-SOD for the
indicated time. Cells were scraped into radio-immunoprecipitation
assay lysis buffer (120 mM NaCl, 1.0% Triton X-100, 20 mM Tris–
HCl, pH 7.5, 10% glycerol, 2 mM EDTA, protease inhibitor cocktail
(Roche GmbH, Germany) and the protein concentration in each
sample was determined using a Bio-Rad protein assay kit with BSA
as the standard. For immunoblotting, 40 μg of protein lysate per
sample was denatured in 4 SDS–PAGE sample buffers and re-
solved by 8–12% SDS–PAGE, transferred to a PVDF membrane
(Millipore, Germany), blocked with nonfat milk, and probed for
PARP, Mn-SOD using HRP-conjugated appropriate secondary anti-
body. The enhanced chemiluminescence was detected using the
Femto chemiluminescence detection system (Pierce Chemical,
Rockford, IL, USA). Membranes were stripped and re-probed with
β-actin (ICN Biomedicals, USA) primary antibody (1:10,000) as a
protein loading control. Densitometry was performed using Image
J software.2.8. Isolation and culture of ventricular myocytes
The experimental procedure used in this study was approved
by the Institutional Animal Ethical Committee at the National
Centre for Cell Science, Pune, India. Adult rat cardiomyocytes were
isolated as described previously [3,30]. Isolated myocytes were
then treated with 5.5 and 33 mM glucose with or without 10 nM
ML1.
2.9. Cell shortening/ re-lengthening and intracellular Ca2þ ﬂuores-
cence measurement in adult cardiomyocytes
The mechanical properties of ventricular myocytes were as-
sessed using a SoftEdge MyoCam system (IonOptix Corp., Milton,
MA, USA) [3,30]. After 24 h treatment of cells with HG, cell
shortening and relenghthening were assessed using the following
indices: peak shortening (PS)—indicative of peak ventricular con-
tractility, time to PS (TPS)—indicative of contraction duration, time
to 90% relenghthening (TR90)—representing cardiomyocyte re-
laxation duration, and maximal velocities of shortening (þdL/dt)
and relenghthening (dL/dt)—indicators of maximal velocities of
ventricular pressure rise/fall. Myocytes were loaded with Fura-
2AM (0.5 μM) for 10 min and ﬂuorescence measurements were
recorded. Resting calcium, qualitative changes in the intracellular
calcium, and ﬂuorescence decay time (Tau) were measured. Both
single- and biexponential curve-ﬁt programs were applied to cal-
culate the intracellular Ca2þ decay constant [3,30]. At least 25
individual cardiomyocytes isolated from 3 to 5 Wistar rats were
used for data collection. Changes in [Ca]i were calculated by de-
termining the rise in [Ca]i relative to basal levels measured
Fig. 2. ML1 restores mitochondrial function via upregulation of Mn-SOD. (A) Mitochondrial superoxide production was quantiﬁed using Mitosox™ red. (C) Mitochondrial
membrane potential was determined using DiOC6. (E) Peroxynitrite production was assessed using DHR-123. (B, D, F) Fluorescence intensity proﬁles were quantiﬁed using
Image J software for above mentioned experiments. Columns, mean from three independent experiments performed in triplicate; bars, SE. *Po0.05, ***Po0.001 versus NG
and ##Po0.01, ###Po0.001 versus HG, þ þPo0.01 versus HGþSOD. (G, H) Mn-SOD expression was studied using western blotting and quantiﬁed using Image J software.
Image representative of three independent experiments and fold change plotted according to represented blot. Statistical analysis was performed using student's t test.
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2.10. Statistical analysis
All experiments were performed at least three times for each
determination. Data are expressed as means7standard error (SE)
and were analyzed using one-way analysis of variance using Tu-
keys post hoc correction and secondary analysis for signiﬁcance
was carried out with Student's t test using Prism 4.0 GraphPad
software (GraphPad, San Diego, CA, USA). Differences were con-
sidered to be signiﬁcant at Po0.05.3. Results
3.1. The Cytoprotective effect of ML1 in H9c2 line.
In order to study the cardio-protection of ML1 against high
glucose, we used a rat cardiac myoblast H9c2 cell line. ML1 when
given alone at concentrations of 10, 50, 100 nM (without HG) did
not show any toxicity, as shown in Fig. 1A. The mitochondrial Mn-SOD (100U), which served as a positive control, could not prevent
HG-induced H9c2 cell death, however all the concentrations of
ML1 signiﬁcantly abrogated HG induced cytotoxicity (Fig. 1A). To
determine whether the observed cytoprotective effects of ML1 was
a measure of its anti-oxidant potential, we incubated these cells
with an exogenous ·−O2 , generator XanthineþXanthine Oxidase
(XþXO). Interestingly, ML1 also inhibited cell death induced by
the XþXO, but the effect was more pronounced at lower con-
centrations of ML1 (10 nM) and was less effective at higher con-
centrations (Fig. 1B).The protective effect of ML1 on HG-induced
cell viability in H9c2 cells was further demonstrated by inhibition
of PARP cleavage. As shown in Fig. 1C, pretreatment with ML1 (10
and 50 nM) signiﬁcantly reduced PARP cleavage induced by HG in
H9c2 cells. However, SOD (100U), which served as a positive
control, did not prevent PARP cleavage at this concentration.
3.2. The effect of ML1 on mitochondrial superoxide ( ·−O2 ) and per-
oxynitrite production and Mn-SOD expression
Although not a strong oxidant itself, ·−O2 , the product of a one-
electron reduction of oxygen, is the precursor of most ROS and a
Fig. 3. ML1 prevents cytochrome c release. Cytochrome c release was observed by confocal microscopy. Mitochondria were labeled using Mitotracker red, cytochrome c antibody
was detected using Cy2-conjugated goat anti-rabbit secondary antibody and nuclei were counterstained using DAPI. Image representative of three independent experiments.
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properly, ·−O2 may react with NO and generate a very powerful and
toxic oxidant, peroxynitrite (ONOO) [32,33]. Therefore, we de-
termined the intracellular levels of mitochondrial ·−O2 using Mito-
sox™ red and peroxynitrite using DHR 123. Fig. 2 demonstrated
that when administrated prior (2 h) to HG treatment for 48 h, ML1
(10 nM) suppressed mitochondrial ·−O2 generation (Fig. 2A and B)
and peroxynitrite generation (Fig. 2E and F) in HG-treated H9c2
cells, indicating a putative antioxidant property of the SOD mimic.
Since an increase in mitochondrial ROS generation leads to a de-
crease in mitochondrial membrane potential, we further evaluated
the efﬁciency of ML-1 in restoring HG-induced mitochondrial
depolarization in H9c2 cells. The molecular probe DiOC6 was used
to assess mitochondrial membrane depolarization. DiOC6 is a mi-
tochondria speciﬁc ﬂuorescent dye and is widely used in mon-
itoringΔΨm because it offers the important advantage that it does
not show major quenching effects [34,35]. As shown in Fig. 2.C and
D, treatment with HG leaded to a decrease in ﬂuorescence in-
tensity indicating loss of ΔΨm. Pretreatment with ML1 restored
the loss of mitochondrial membrane potential in cells exposed to
HG. Interestingly, ML1 afforded comparatively better protection
than SOD with respect to the aforementioned measures of HG
induced oxidative stress (Fig. 2 B, D and F). Further investigation
into the anti-oxidative mechanism of ML1 demonstrated that
HG-induced a decrease in the expression of Mn-SOD, one of themajor and precursor antioxidant enzymes, capable of dismutating
·−O2 , into H2O2. This was attenuated by pretreatment with ML1
(10 nM) (Fig. 2G and H). No effect was seen when ML1 was given
alone (without HG). These ﬁndings indicate that ML1 decreases
HG-induced mitochondrial ·−O2 and ONOO
 partly through up-
regulation of Mn-SOD activity. These results suggest that the an-
tioxidant enzyme Mn-SOD plays an important role in the anti-
apoptotic action of ML1 against HG-induced damage.3.3. ML1 attenuated HG-induced cytochrome c release.
It is well known that mitochondria play a pivotal role in cell
death/ survival and that mitochondrial dysfunction constitutes a
critical event in the apoptotic process. ΔΨm is a critical factor in
maintaining the integrity of mitochondria and subsequent reg-
ulation of apoptosis. Loss of ΔΨm will lead to release of cyto-
chrome c from mitochondria, which in turn activates downstream
caspases and causes PARP cleavage, an endogenous caspase sub-
strate to cause apoptosis [36,37]. Thus we evaluated the effect of
ML1 on HG-induced cytochrome c release from mitochondria. In
the untreated cells, cytochrome c co-localized in the mitochondria
(Fig. 3), however after exposure of H9c2 cells to HG, cytochrome c
was observed to have diffused out from the mitochondria at 72 h.
This HG induced release of cytochrome c was attenuated by ML1.
Fig. 4. ML1 inhibited HG-induced mitochondrial calcium overload. (A) Protection by ML1 against HG induced mitochondrial calcium was evaluated using Rhod-2AM. (B) Mean
ﬂuorescence intensity (MFI) was analyzed using image J software. (C) Ability of ML1 to counter external calcium induction was assessed using Rhod-2 AM. (D) Mean ﬂuorescence
intensity (MFI) was analyzed using image J software. Image representative of three independent experiments. Columns, mean from three independent experiments performed in
triplicate; bars, SE. *Po0.05, **Po0.01 versus NG, ##Po0.01 versus HG, $$Po0.01 versus XþXO, §§§Po0.001 versus calcium and þ þPo0.01 versus ionomycin.
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As shown in previous studies, high glucose conditions lead to an
increase in mitochondrial calcium overload which is one of the main
pathological stimuli for the induction of diabetic cardiomyopathy [23].
An increase in intracellular calcium is implicated in elevating mi-
tochondrial ROS levels and further reducing membrane potential, thus
facilitating the release of apoptogenic cytochrome c [38–41], ulti-
mately providing the premise for ischemic heart disease. Therefore, to
examine whether the mitochondrial calcium overload can be ame-
liorated by the protective effect of ML1 on HG-induced apoptosis, the
molecular probe Rhod-2AM was used to assess mitochondrial calcium
accumulation. Treatment with HG leads to an increase in the ﬂuor-
escence levels, indicative of accumulation of Ca2þ into the mi-
tochondria. This could be inhibited by pretreatment with ML1 as well
as SOD (Fig. 4A and B). The exogenous ·−O2 , generator XþXO also in-
creased Rhod-2 ﬂuorescence, but to a relatively low extent. Both SOD
and ML1 abolished the rise in Rhod-2 ﬂuorescence completely
(Fig. 4A, B). Calcium chloride (CaCl2) and the Ca2þ mobilizing com-
pound, ionomycin used as positive controls for mitochondrial calcium
overload [42–45] also lead to an increase in mitochondrial Ca2þ ac-
cumulation which was inhibited by both the calcium chelator EGTA as
well as ML1 (Fig. 4C and D).
3.5. ML1 protects against high-glucose-induced abnormalities in
relaxation in rat ventricular myocytes
Culturing myocytes for 24 h with either HG or ML1 had noovert effect on cell phenotype. Cell shape, resting cell length,
and presence of distinct striations were similar in cells among
the two groups. Representative traces of cell shortening and re-
lengthening are shown in Fig. 5A. Consistent with previous reports
[5,45–47], myocytes maintained in high-glucose medium had a
reduced peak shortening amplitude (Fig. 5B) associated with
decreased maximal velocity of shortening and relenghthening
(7dL/dt) (Fig. 5A), elevated time-to-peak shortening (TPS)
(Fig. 5C), and prolonged time to- 90% relenghthening (TR90)
(Fig. 5D) compared to those of normal myocytes. The reduced peak
shortening, 7dL/dt, elevated TPS and prolonged TR90 in HG
myocytes were abolished by co-incubation of the cells with 10 nM
ML1 (Fig. 5B–D).
3.6. Effect of ML1 on intracellular Ca2þ ([Ca2þ]i) transients
To determine whether the differential response of ML1 in NG
and HG cultured ventricular myocytes was due to changes in in-
tracellular Ca2þ concentration, we used the ﬂuorescent dye fura-2
to estimate intracellular Ca2þ transient properties in myocytes
from both groups. Earlier studies have also shown that prolonged
relaxation in HG-treated cells is accompanied by slower in-
tracellular Ca2þ clearing [45,46,48]. Since ML1 prevented HG-in-
duced relaxation dysfunctions, we wanted to determine whether
this effect coincided with changes in intracellular Ca2þ . Resting
[Ca2þ]i, electrical stimulus-induced increase in intracellular Ca2þ
(Δ[Ca2þ]i), and cytosolic free Ca2þ decrease rate (tau) were
evaluated in fura-2 loaded myocytes. HG myocytes showed similar
Fig. 5. ML1 rescues ARVMs from high-glucose-induced abnormalities in relaxation. High glucose induced (A) shortening and re-lengthening (7dL/dt) (B) peak shortening
amplitude (C) time-to-peak shortening (TPS) and (D) time to- 90% re-lengthening (TR90) were studied using a SoftEdge MyoCam system. Columns, mean from three
independent experiments performed in triplicate; bars, SE. *Po0.05 versus NG, #Po0.05, ##Po0.01 versus HG.
Fig. 6. ML1 modulates intracellular calcium transients. High glucose mediated changes in (A) resting [Ca2þ]I, (B) intracellular calcium Δ[Ca2þ]i and (C) cytosolic-free Ca2þ
release rate, Tau were detected using a SoftEdge MyoCam system. Columns, mean from three independent experiments performed in triplicate; bars, SE. *Po0.05 versus NG,
#Po0.05 versus HG.
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with slower cytosolic-free Ca2þ (Fig. 6C) decrease compared to
normal myocytes, consistent with reduced peak shortening and
prolonged TR90. ML1 (10 nM) abolished the HG-induced reduction
of Δ[Ca2þ]i and prolonged cytosolic free Ca2þ decrease (Fig. 6B
and C).4. Discussion
In this work, we show that ML-1, a novel SOD mimic with a
redox-modulating Mn (II) complex inhibits mitochondrial dys-
function in H9c2 cells, in which it prevents ROS and hyperglyce-
mia-induced cell death. It also rescues HG-induced abnormalities
V. Kain et al. / Biochemistry and Biophysics Reports 5 (2016) 296–304 303in myocyte relaxation, in an ex-vivo ARVM model. We propose
that the protective effect of ML1 manifests through its antioxidant
potential, and might be responsible for stalling HG stress induced
apoptotic events.
As reported in our previous study [22], ML1 appears to exert
superior protection against oxidative damage in Hek293 kidney
cells, as compared with Mn-SOD, used here as a positive control. In
the present study, H9c2 cells exposed to 33 mM of glucose de-
creased cell viability while pre-treatment with ML1 restored cell
viability. The results of this MTT assay are based mainly on the
enzymatic conversion of MTT within the mitochondria by succi-
nate dehydrogenase, which suggests that the early signs of glucose
toxicity could be based on mitochondrial dysfunction. This in-
dicates that the mitochondrion-driven apoptotic pathway is clo-
sely linked to glucose metabolism. The protective effect of ML1
was further conﬁrmed by its inhibition of HG and XþXO induced
PARP cleavage, an event associated with DNA damage and cell
death. The fact that Mn-SOD was able to inhibit PARP cleavage due
to XþXO induced cytotoxicityand was ineffective against High
glucose stress, indicates that Mn-SOD is able to counter only acute
ROS production by XþXO, whereas ML-1 can inhibit both the
acute and, HG mediated chronic toxicity. The harmful effects of
ROS on cells is widely appreciated, and ﬁndings from our previous
studies [22] as well in the current study conﬁrm that exogenous
oxidizing agent XþXO alters cell viability irrespective of the cell
type. This implies that the adverse effects of hyperglycemia in
cultured cardiac cells are at least partly attributable to the occur-
rence of an oxidative stress. The fact that ML1 prevents XþXO
induced cell death in H9c2 cells suggests that ML1 may affect an
event that follows ROS generation.
Calcium overload and oxidative insult are the two mutually
non-exclusive phenomena suggested to cause cardiac dysfunction.
The involvement of oxidative and/or nitrosative stress [1,23] and
an alteration in calcium homeostasis due to Ca2þ overload [23,49]
in the pathogenesis of diabetic cardiomyopathy has been im-
plicated in experimental animal studies and in patients. The
overproduction of superoxide and its associated peroxynitrite have
been recognized as an important contributor to diabetic vascular
complications [6,7]. Oxidative stress, induced by reactive oxygen
and nitrogen species derived from hyperglycemia, causes abnor-
mal gene expression, altered signal transduction, and the activa-
tion of pathways leading to programmed myocardial cell death.
This is evident from our studies, where exposure of H9c2 cells to
HG leads to increased ·−O2 and ONOO
 levels. An upregulation of
Mn-SOD levels along with an effective quenching of free radicals
provides further proof of the anti-oxidant potential of ML1.
Among various effects of ROS on cell metabolism, reduction in
mitochondrial membrane potential (ΔΨm) which is the rate lim-
iting manifestation of mitochondrial cell death is of crucial im-
portance [50]. The fact that HG-induced oxidative stress reduced
mitochondrial membrane potential, facilitated cytochrome c re-
lease and PARP cleavage, whereas ML1 prevented all of these
events, strongly suggests that oxidative stress induced cytotoxicity
in cardiac cells is mainly due to mitochondrial dysfunction.
ML1restored mitochondrial membrane potential and blocked the
release of cytochrome c, probably by neutralizing ROS and RNS
toxicity. This property was found to be superior to exogenously
added SOD, hinting at the cellular permeability of ML1.
The reason for inhibition of mitochondrial Ca2þ over load in HG
treated cells by ML1 could be attributed to inhibition of excessive
ROS production, however, it could also relate to its inhibition of
mitochondrial ATP-sensitive potassium channel (mitoKATP) chan-
nels, since studies in cardiac myocytes have shown that mitoKATP
is activated by superoxide and hydrogen peroxide and is regulated
in a redox-dependent manner by reactive nitrogen species [51].
This channel may also facilitate ROS-mediated cell death in highglucose treated cardiac cells, possibly by acting as an uncoupling
agent that decreases membrane potential and mitochondrial cal-
cium overload, as in the case of ischemic preconditioning [52]
although the precise mechanism remains unclear.
Further, we took advantage of a cardiac myocyte culture model
developed in our laboratory, where diabetic cardiomyopathy could
be phenotypically replicated in normal myocytes by culturing in a
high glucose medium. It has been well established that high glu-
cose impairs cardiac E-C coupling and induces contractile dys-
functions in isolated cardiomyocytes [5,46,48]. The abnormal car-
diac E-C coupling is apparent in high glucose-treated myocytes
reminiscent of those from in vivo diabetes [4]. The freshly isolated
myocytes from diabetic rats, and normal myocytes cultured in HG-
containing medium, exhibit prolonged relaxation and slowed cy-
tosolic Ca2þ removal [4,46,48]. Prolonged relaxation associated
with slow intracellular Ca2þextrusion is the most consistent fea-
ture in diabetic cardiomyopathy as inferred from previous ex-
periments [5,7,28,53]. In the current study, ML1 improved HG-
induced relaxation dysfunction without affecting mechanical in-
dices in normal cells. This effect is associated with the improve-
ment of cytosolic Ca2þ clearing, which may underlie ML1 activity.
Elevated extracellular glucose leads to increased intracellular Ca2þ
in both vascular smooth muscle [5] and cardiomyocytes [49,54],
which may be responsible for altered E-C coupling. These altera-
tions may cause changes in intracellular Ca2þ homeostasis and, in
turn, the cardiac defects [55]. We measured calcium transients in
diabetic rat myocytes and demonstrated a decrease in both the
peak amplitude and the rate of decay of calcium transients, sug-
gesting a depression in SR calcium handling.
In summary, this study underlines the important role of mi-
tochondrial superoxide overproduction and calcium overload in
diabetic cardiomyopathy and indicates that treatment with low
molecular weight SOD mimetics can be beneﬁcial in preserving
cardiac contractility in this disease. Our study suggests that ML1
could be a potential therapeutic agent for diabetic cardiac dis-
orders and other disorders that involve oxidative stress associated
with mitochondrial injury. However, a much more detailed study
delineating its mechanism of action would reveal valuable targets
for novel therapeutics aimed at preventing diabetes related cardiac
diseases including DCM more efﬁciently.Acknowledgment
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